跳至主要内容
临床试验/NCT02440152
NCT02440152Unknown2 期

The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention

Ruijin Hospital2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2017年2月1日最近更新:
适应症

试验速览

阶段
2 期
入组人数
6
试验地点
2
主要终点
Weekly urine tests

研究概览

简要总结

The nucleus accumbens (NAcc) has a significant role in the process of opiate addiction and the initiation of relapse after detoxification. There is evidence that deep brain stimulation (DBS) of the NAcc exerts a positive effect on individuals with severe heroin addiction via inhibitory action .

The investigators hypothesise that bilateral stimulation of the NAcc will significantly reduce withdrawal symptoms and thus enable the patients to substantially decrease their Levomethadone usage.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Proficiency in Mandarin language
  • Long lasting heroin addiction (determined by diagnostic-criteria in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition)
  • Duration longer than 6 months
  • A lack of response to long-term treatment
  • Capacity to provide informed consent (understanding of the study purpose and methods)
  • Substitution methadone treatment at a constant dose within three months prior to inclusion.

排除标准

  • Clinical relevant psychiatric comorbidity (schizophrenic psychoses, bipolar affective diseases with psychotic symptoms)(MINI 6.0)
  • Past stereotactic neurosurgical intervention
  • Neurological disease (Abnormal PET-CT, MRI, EEG)
  • Contraindications of MRI-examination, e.g. implanted cardiac pacemaker/ heart defibrillator
  • Contraindications of stereotactic intervention, e.g. increased bleeding-disposition, cerebrovascular diseases (e.g. arteriovenous malfunction, aneurysms, systemic vascular diseases)
  • Serious and unstable organic diseases (e.g. unstable coronal heart disease)
  • HIV positive
  • Pregnancy and/or lactation

结局指标

主要结局

Weekly urine tests

时间窗: Baseline (preoperative), 3 months, 6 months, 9 months, 12 months, 18 months, 24 months

次要结局

  • Change in Hamilton Depression Scale-17(Baseline (preoperative), 3 months, 6 months, 9 months, 12 months, 18 months, 24 months)
  • Change in 10-point visual analog scale (VAS) craving score for opioid drugs(Baseline (preoperative), 3 months, 6 months, 9 months, 12 months, 18 months, 24 months)
  • Change in SF-36 assessment(Baseline (preoperative), 6 months, 12 month, 24 month)
  • Change in Hamilton Anxiety Scale(Baseline (preoperative), 3 months, 6 months, 9 months, 12 months, 18 months, 24 months)
  • Neuropsychological measures(Scores of Iowa gambling task and Model task)(Baseline (preoperative), Intraoperative,6 months,12month,24month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bomin Sun

Department of Functional Neurosurgery

Ruijin Hospital

研究点 (2)

Loading locations...

相似试验